VivoSim Labs, Inc. Interest Expense Nonoperating
VivoSim Labs, Inc. (VIVS) reported Interest Expense Nonoperating of $4.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-12
- VivoSim Labs, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $4.00K, a 0.00% change year-over-year.
- VivoSim Labs, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $4.00K, a 20.00% decline year-over-year.
- VivoSim Labs, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $4.00K, a 20.00% decline year-over-year.
- VivoSim Labs, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $0.00.
- VivoSim Labs, Inc. interest expense nonoperating for fiscal 2026 was $12.00K, a 20.00% increase from fiscal 2025.
- VivoSim Labs, Inc. interest expense nonoperating for fiscal 2025 was $10.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.00K 10-Q · filed 2026-08-12 | $8.00K derived: sum of 2 quarters · filed 2026-08-12 | $12.00K derived: sum of 3 quarters · filed 2026-08-12 | $12.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $8.00K derived: sum of 2 quarters · filed 2026-07-14 | $8.00K derived: sum of 3 quarters · filed 2026-07-14 | $12.00K 10-K · filed 2026-07-14 |
| 2025-12-31 | $4.00K 10-Q · filed 2026-02-11 | $4.00K derived: sum of 2 quarters · filed 2026-02-11 | $8.00K 10-Q · filed 2026-02-11 | $13.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $4.00K 10-Q · filed 2025-11-06 | $9.00K derived: sum of 3 quarters · filed 2026-08-12 | $14.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $4.00K 10-Q · filed 2026-08-12 | $9.00K derived: sum of 2 quarters · filed 2026-08-12 | $14.00K derived: sum of 3 quarters · filed 2026-08-12 | $14.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $10.00K derived: sum of 2 quarters · filed 2026-07-14 | $10.00K derived: sum of 3 quarters · filed 2026-07-14 | $10.00K 10-K · filed 2026-07-14 |
| 2024-12-31 | $5.00K 10-Q · filed 2026-02-11 | $5.00K derived: sum of 2 quarters · filed 2026-02-11 | $5.00K 10-Q · filed 2026-02-11 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $0.00 10-Q · filed 2025-02-19 | $0.00 10-Q · filed 2025-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |